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In Vivo Metabolism of 3,2'*Dimethyl*4
Aminobiphenyl (DMAB) Bearing on Its
Organotropism in the Syrian Golden
Hamster and the F344 Rat.
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and John H. Weisburger*
The in vivo metabolism of tritiated DMAB was examined in male Syrian golden hamsters, which
are susceptible to both urinary bladder and intestinal carcinogenesis by this agent and in male
F344 rats in which intestinal tumors represent the main lesions. Evidence was obtained for the pres-
ence of the N-hydroxy-N-glucuronide of DMAB as a major metabolite in hamster urine and bile and
in rat bile but not urine. The routes of excretion of this metabolite, which may represent a transport
form of the ultimate carcinogen, correlate well with the main tumor sites in the two species. Other
metabolites partially identified were the sulfates and glucuronides of C-hydroxylated DMAB and C-
hydroxylated-N-acetyl DMAB.
Introduction
During comparative carcinogenicity studies with
various derivatives of 4-aminobiphenyl, Walpole et
al. (1-3) observed that the introduction of a methyl
group ortho to the amine function (3-methyl-4-amino-
biphenyl) resulted in increased carcinogenicity to-
wards the intestinal tract of rats. On the other
hand, methyl substitution meta to the amine (2-
methyl-4-aminobiphenyl) decreased the carcinogenic-
ity and changed the organotropism, with the ap-
pearance of liver rather than intestinal tumors. The
introduction of a second methyl group at the 2' posi-
tion to give 3,2'-dimethyl-4-aminobiphenyl (DMAB),
enhanced the carcinogenicity toward the intestinal
tract even further; moreover significant carcinoge-
nicity appeared toward the ear duct, the salivary
gland and other organs. Interestingly a methoxy
group ortho to the amine produced a carcinogen
with organotropism toward the urinary bladder.
These relationships are summarized in Table 1. To
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explain the carcinogenicity of 4-aminobiphenyl, 3-
methyl-4-aminobiphenyl and DMAB toward the
small and large intestines, Walpole speculated (1)
that the effective carcinogen of the amines was a
metabolite excreted in the bile.
Because of the great interest in animal models for
colorectal cancer which would accurately reflect the
disease in man, DMAB was utilized by Spjut et al.
(4-6), and So and Wynder (7) and others (8) to study
the induction and development of colon cancer in ro-
dents. In experiments designed to test Walpole's
suggestion that metabolites of DMAB acted topi-
cally on the intestine, Navarrette-Reyna and Spjut
(9) performed colostomies 4 cm above the rectum in
rats. Following the SC administration of DMAB,
they found that tumors were found exclusively in
the intestine proximal to the colostomy. Other ex-
periments by Cleveland et al. (10), involving the SC
administration of DMAB to rats with surgically de-
functionalized colon segments, similarly indicated
that tumors appeared only in those segments which
were in actual contact with the fecal stream. These
experiments provided strong evidence that the in-
duction of tumors in the intestine was related to the
transport of some form of the carcinogen via theNUSSBA UMETAL.
Table 1. Incidence of tumors in albino Wistar rats.i'
Incidence of tumors
Total dose Intestine Bladder Mammary Salivary Ear duct Liver SC, G/KG
NH2 3.6-5.8 7/14 - 3/12(0) - -
H3
( NH;! 1.2 12/23 - - - 3 23 -
ICH3 H3
H 2 2.8-3.5 21/23 1/23 1,12(0) 5 23 4 23 0
CH3
NJ 2 2.4 - - - - 3 23
H3
Q Q N H Z 44 - 9/10 -
"Data from Walpole et al. (1-3).
bile and intestinal contents rather than by the blood
stream.
In the experiments of So and Wynder (7), an in-
teresting species difference in the response to
DMAB was observed: whereas in the rat the pre-
dominant sites of tumors were the small and large
intestine, in the hamster DMAB caused a high inci-
dence of tumors in the urinary bladder. This species
difference was confirmed by later work (11, 12) and
is illustrated in Table 2.
To attempt to elucidate the mechanisms of the
contrasting organotropisms of DMAB in the rat and
hamster, we began studies on the in vivo (13) as
Table 2. Organotropism of3.2-dimethyl-4-aminobiphenyl in
male Syrian golden hamsters and F344 rats.a
Incidence,%
Organ Hamsters (25) Rats (26)
Stomach, squamous papillomas 48 0
Urinary bladder, carcinoma 64 0
Small intestine, adenocarcinoma 28 35
Colon, adenocarcinoma 24 31
Ear duct 0 8
Lung 0 19
Skin 0 54
Subcutaneous tissue 0 23
Prostate, carcinoma in situ 0 19
aData of Fiala et al. (12).
well as the in vitro metabolism of the carcinogen.




Male outbred Syrian golden hamsters and male
F344 rats were obtained from Charles River Breed-
ing Laboratories. The animals were maintained on
NIH-07 diet and water ad libitum. The approximate
mean weight of the hamsters used for these studies
was 175 g; that of the rats was 225 g.
Chemicals
DMAB HCl was obtained from Ash Stevens, De-
troit, Mich. The material was custom tritiated by
New England Nuclear Corp. For purification, 25-30
mCi of the tritiated DMAB was mixed with 0.5-1.0 g
of unlabeled DMAB HCl in a small volume of ether.
After conversion of the HC1 salt to the free base by
addition of an excess of saturated NaHCO3 solution
with stirring, the mixture was extracted several
times with ether. The ether extracts were combined
and passed through ClinElut columns (Fisher Scien-
tific) to remove water and concentrated by rotary
evaporation to yield a viscous oil. This was diluted
with an equal volume of ether and applied to an
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E.M. Merck size C Lobar silica gel column equili-
brated with n-hexane-ethanol, 96:4 (v/v). The column
was eluted with the same solvent at a rate of 0.5
mL/min. After determination of radioactivity, frac-
tions containing DMAB were identified by serially
spotting aliquots onto a TLC plate and spraying
with Ehrlich reagent (14). The fractions showing a
yellow color on the plate with the reagent were
pooled and concentrated to yield a clear viscous oil
which turned into a white solid on storage at 4°C.
The radiochemical purity was > 97% by TLC on sil-
ica gel [benzene-CHCl3-ethyl acetate-methanol,
70:15:15:3 (v/v); Rf = 0.63] and by HPLC [two
Waters /Bondapak C18 columns in series eluted with
methanol-H20, 75:25, (v/v); elution volume, 11.5 ml].
For use as chromatographic standards, the N-hy-
droxy and C-nitroso derivatives were synthesized
from DMAB by the method described by Hecht et
al. (15).
For enzymatic hydrolyses, E. coli P-glucuronidase
(Sigma type IX) and Helix pomatia aryl sulfatase
(Sigma type H-1) were used. All other chemicals and
solvents were reagent or HPLC grade and distilled
deionized H20 was used in all phases of these ex-
periments.
Collection of Bile
Rats or hamsters were anesthetized and the com-
mon bile duct was cannulated with polyethylene
tubing, size No. 1. In early experiments, ether was
used as the anesthetic. In later experiments, ether
was used in combination with halothane for more
uniform anesthesia. No differences in biliary excre-
tion which could be ascribed to the method of anes-
thesia were noted. In the rat, the cannula emerged
from the animal by way of the posterior aspect of
the hind leg. In the hamster, the gall bladder was li-
gated before cannulation of the bile duct and the
cannula was channeled subcutaneously to the inter-
scapular area and exteriorized at that point. Triti-
ated DMAB was suspended in corn oil and was in-
jected SC at a dose level of 75 mg/kg immediately
after the cannulation of the bile duct. Approxi-
mately a 20 ,.Ci dose was given to each animal. The
animals were placed in plastic restrainers and bile
was collected in test tubes cooled to 0-40C.
Collection of Urine
Nonoperated animals were treated with tritiated
DMAB as above and placed in stainless steel metab-
olism cages with provisions for the separation of
urine and feces. Urine was collected at 0-40C in con-
tainers to which 0.5 mL of 0.5M triethylamine-CO2
buffer, pH 8.0, was added to maintain alkaline pH.
All animals had free access to food and water dur-
ing either bile or urine collection.
Sephadex LH-20 Chromatography
For most of the experiments described here, a
wet-packed 1.5 x 110 cm column of Sephadex LH-
20 (25-100 ,um) equilibrated with methanol-H20-
0.5M triethylamine-CO2 buffer, pH 8.0, 100:100:2
(vlv), was used. The column was eluted at a rate of
12 mLlhr, and 6 mL fractions were collected. The in-
clusion of the triethylamine buffer in the eluant
served not only to maintain moderately alkaline pH,
but also appeared to increase resolution signifi-
cantly, an effect which might be due in part to ion-
pairing with the acid conjugated metabolites. The
separation of conjugated urinary o-toluidine metabo-
lites by this technique was reported by us earlier
(16).
Thin-Layer Chromatography
Silica gel G or GF plates, 250,m, were obtained
from Analtech, Newark, Del. For the separation of
glucuronic and sulfuric acid conjugates, the plates
were developed with n-butanol-acetic acid-water,
3:1:1 (vlv). We refer to this as system A. For the
separation ofDMAB, 3,2'-dimethyl-4-nitrosobiphenyl,
and various aglycones from enzymatic hydrolyses,.
the plates were developed with system B: benzene-
chloroform-ethyl acetate-methanol, 70:15:15:3 (v/v).
High Pressure Liquid Chromatography
A Waters Model M600A HPLC pump with a
U6K injector was used in conjunction with a Schoef-
feVKratos SF 770 variable wavelength monitor.
Mass Spectrometry
Mass spectra were obtained with a Hewlett-Pack-
ard 5980A mass spectrometer, equipped with a
Model 5933A data system, at 70 eV with a source
temperature of 175-180°C.
Total Urinary and Biliary Radioactivity
A comparison of the total amount of radioactivity
excreted in a 24-hr period after dosing with 75 mg/
kg of tritiated DMAB by the rat and hamster via
the bile and urine is shown in Figure 1. While the
rat excreted approximately 6% of the dose in the
urine and 12% in the bile, the hamster excreted ap-
proximately 17% in the urine and 5% in the bile. In
those cases where collections were extended to 48
hrs, the rats excreted an additional 5.6 + 2.6% of
the dose in the urine, 10.9 ± 3.10% in the bile, and
the hamsters excreted an additional 3.9 ± 1.6% in
the urine and 3.1% (only one hamster with a bile fis-











FIGURE 1. Excretion of radioactivity in rat and hamster
urine and bile in 24 hr following an SC injection of tritiated
DMAB (75 mg/kg). Parentheses denote number of animals
used.
Separation of DMAB Metabolites
Submission of the 0-24 hr samples of bile and
urine of the two species to Sephadex LH-20 chroma-
tography yielded the metabolite profiles shown in
Figures 2 and 3. While only three major metabo-
lites, designated a, P and y were resolved from rat
bile, at least seven metabolite peaks were detected
in rat urine (Fig. 2). Peaks P and y were present in
both bile and urine, peak a, a major component was
present only in the bile while peaks 6 and E and two
other late-eluting minor peaks were present in
significant amounts only in the urine.
In the hamster (Fig. 3), peaks corresponding to
the elution volumes of rat metabolites a, P and y
were present in both bile and urine, and peak a was
the major metabolite in both fluids.
Sephadex LH-20 peaks a and P from rat bile, ham-
ster bile or rat and hamster urine were positive for
glucuronic acid by the naphthoresorcinol reaction,
as described by Mead et al. (17), indicating glucu-
ronic acid conjugates.
TLC of combined concentrated fractions compris-
ing a peak a on silica gel plates eluted with system
A showed one radioactive peak near the solvent
front which developed yellow color immediately
with Ehrlich reagent but was negative to naphtho-
resorcinol. However, the latter reagent showed a
distinct blue zone on the plate at R_ = 0.42 which
was devoid of radioactivity and which corresponded
to free glucuronic acid. This suggested that a glucu-
ronic acid conjugate in peak a was hydrolyzed by
the acid TLC solvent.
To determine whether or not this was the case, a
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FIGURE 2. Sephadex LH-20 profiles of DMAB metabolites in
rat urine and rat bile collected for 24 hr following tritiated
DMAB administration.
rat bile was adjusted to pH 5.0 with sodium acetate
buffer and incubated at 370C. Aliquots were taken
periodically and submitted to reverse-phase HPLC
using methanol-water, 75:25 (vlv), as eluant. With
increasing time of incubation, radioactivity in the
most polar peak gradually decreased with corre-
sponding increases in radioactivity in peaks at elu-
tion volumes of 8.5 and 16.5 mL (Fig. 4). The elution
volumes of these peaks corresponded exactly to
those of DMAB and 3,2'-dimethyl-4-nitrosobiphenyl
standards, respectively. At short times of incuba-
tion, e.g., 30-60 minutes, a radioactive peak ap-
peared at an elution volume of 7.0 mL which corre-
sponded to N-hydroxy-DMAB. This peak disap-
peared after longer times of incubation, presumably
due to further oxidation to the nitroso form. After 3
hr of incubation, the mixture was extracted with
ether and the ether extract submitted to TLC using
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FIGURE 3. Sephadex LH-20 profiles of DMAB metabolites in
hamster urine and hamster bile collected for 24 hr follow-
ing tritiated DMAB administration.
solvent system B. Two major radioactive ultravio-
let-absorbing bands were observed at Rf = 0.63,
corresponding to DMAB, and at Rf = 0.79, corre-
sponding to 3,2'-dimethyl-4-nitrosobiphenyl. These
bands were eluted and submitted to mass spectrom-
etry (Fig. 5) whereby their identity was confirmed.
The time course of hydrolysis of the a peak from
rat bile at pH values of 5.0, 6.2 and 7.8 is shown in
Figure 6. At pH 7.8 very little hydrolysis occurred
over the 3-hr period, but hydrolysis was rapid at pH
6.2 and more so at pH 5.0. At the latter pH approxi-
mately 80% of the a peak was hydrolyzed within 3
hr.
Two alternatives concerning the origin of the
DMAB and the nitroso derivative were considered.
It was possible that the a peak obtained by Sepha-
dex LH-20 chromatography was not homogeneous
and contained the N-glucuronide of DMAB as well
ELUTION VOLUME, ml
FIGURE 4. HPLC analyses of rat bile a peak incubated for
varying times at pH 5 and 370C.
as the N-glucuronide of N-hydroxy-DMAB. Such N-
glucuronides are well known to be hydrolyzed
under mildly acidic conditions (18-21). In the pres-
ence of oxygen, the N-hydroxy-DMAB aglycone
would be rapidly oxidized to the nitroso form. On
the other hand, it was possible that the a peak con-
sisted entirely of the N-hydroxy-N-glucuronide of
DMAB. After hydrolysis, the N-hydroxy aglycone
could conceivably disproportionate to DMAB and
the nitroso product.
To determine which was the case, the a peaks ob-
tained from rat bile and hamster bile and urine
were submitted to HPLC using a .Bondapak C18 col-
umn eluted with 30:70 methanol-water, 0.005M in so-
dium phosphate buffer, pH 8.0. In all cases, two
radioactive peaks, designated al, and a2 and eluting
at approximately 15 and 18 mL, respectively, were
obtained, which were positive for glucuronic acid.
The HPLC resolution of the a peak obtained from
rat bile is shown in Figure 7. Upon mild acid hydro-
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FIGURE 5. Mass spectra of aglycones recovered from mild acid (pH 5) hydrolysis of Sephadex LH-20 peak a.
yielded DMAB as the only component (Fig. 8, upper
trace) whereas hydrolysis and HPLC of a2 yielded
3,2'-dimethyl-4-nitrosobiphenyl as the major compo-
nent and a small amount of DMAB (Fig. 8, lower
trace). This indicates that the Sephadex LH-20 a
peak was in fact composed of two glucuronic acid
conjugates: the N-glucuronide of DMAB (a1) and the
N-hydroxy-N-glucuronide of DMAB (a2). The approx-
imate ratio of a2 to a1 was 5:1 in rat bile, 1:3 in ham-
ster bile and 1:2 in hamster urine, as determined by
HPLC.
Sephadex LH-20 peak P was present in the urines
and biles of both hamsters and rats (Figs. 2 and 3).
On TLC with solvent system A, a naphthoresorcin-
ol-positive, radioactive band with an Rf = 0.74 was
noted in all four cases. A strong immediate reaction
with Ehrlich reagent spray indicated the presence
of a free amine group. FollowingP-glucuronidase hy-
drolysis, the aglycone was recovered by ether ex-
traction and purified by TLC with solvent system B
(Rf = 0.46). The purified aglycone yielded a mass
spectrum (Fig. 9) which is compatible with that of a















FIGURE 6. Time course of hydrolysis of Sephadex LH-20
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FIGURE 8. HPLC of pH 5 hydrolysis products of a, and a2. A







FIGURE 7. Resolution of Sephadex LH-20 peak a (rat bile)
into glucuronides (a, and a2) by HPLC. A ,uBondapak C,,
column was eluted with 30% methanol, 0.005 M sodium
phosphate, pH 8.0.
ring hydroxylated metabolite of DMAB.
Sephadex LH-20 peak y, present in both rat urine
and bile and in hamster urine was positive for glu-
curonic acid. After P-glucuronidase hydrolysis of y
obtained from rat urine, TLC in system B gave a
major radioactive zone with an Rf of 0.27. Mass
spectral analysis of the aglycone yielded distinct
peaks at nme = 255 (M+), 213, 198, 181 and 163. We
infer that peak y represents the glucuronide of N-
acetyl ring-hydroxylated DMAB.
Sephadex LH-20 peak 6, a major metabolite in rat
urine and possibly a minor metabolite in rat bile
and hamster urine gave an Rf of 0.60 on TLC using
solvent system A. The metabolite was negative for
glucuronic acid and gave a yellow color with Ehrlich
reagent which developed only after a period of time.
The greater elution volume of 6 compared to the
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FIGURE 9. Mass spectrum of the aglycone of Sephadex LH-20
peak P. A ring hydroxylated metabolite is indicated; the
position of the hydroxyl group cannot be determined by
mass spectral analysis alone.
effects separations mainly by molecular sieving,
suggested that peak 6 might be a sulfuric acid
conjugate. In fact after incubation with aryl
sulfatase at 370C for 4 hr at 370C, more than 80%
of the total radioactivity was extractable into ether.
The concentrated ether extract gave a single
radioactive band on TLC with system B with an R1
of 0.27. Submission of the eluted aglycone to mass
spectrometry gave a spectrum essentially identical
to that obtained using the aglycone of peak y. Thus
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Discussion
Among the arylamine carcinogens, DMAB is of
interest because it induces colon tumors in rats and
hamsters (1-7, 11), mammary tumors in female rats
(8) and urinary bladder tumors in hamsters (7, 11,
12). Thus, depending on the animal, DMAB provides
a good experimental model for three major sites of
human cancers. Since it contrasts with other colon
carcinogens such as 1,2-dimethylhydrazine whose
activated metabolites reach the colon mucosa via
the blood rather than the fecal stream (22), as is the
case with DMAB (9, 10), clarification of the mode of
action of these carcinogens may yield mutually com-
plementary information that can be relevant to the
as yet unknown etiology of the disease in man.
The distinct differences (excepting the overlap in
the small and large intestines) in the organotropism
of DMAB in the rat and hamster presumably result
from differences in the metabolism and disposition
of the carcinogen. In this respect, it is of interest
that the rat, in which intestinal tumors are the ma-
jor lesions, excretes a greater proportion of DMAB
metabolites in the bile than in the urine (Fig. 1). In
contrast, the hamster, which is sensitive to the de-
velopment of urinary bladder tumors in response to
DMAB, excretes a greater portion of the metabo-
lites in the urine than in the bile.
A still better correlation exists between the pres-
ence of the metabolite which we have identified, al-
beit through indirect methods, as the N-hydroxy-
N-glucuronide of DMAB in the two physiological
fluids and the sites of tumor formation in the two
species. Thus this metabolite is present in both the
bile and urine of hamsters, and is present in rat bile
but not rat urine (Figs. 2 and 3). Because of its insta-
bility, the amount of theN-hydroxy-N-glucuronide is
difficult to quantitate accurately, however we esti-
mate that 4.5% of the DMAB dose is excreted in
this form in rat bile, 1.2% is excreted in hamster
bile and 4.2% is excreted in hamster urine in the
first 24-hr period after dosing.
From the work of Radomski et al. (20, 23, 24) and
Kadlubar et al. (19, 25, 26) it appears that the pres-
ence of the N-hydroxy-N-glucuronide of DMAB in
hamster urine could be directly related to the induc-
tion of urinary bladder tumors in this species. N-Hy-
droxy-N-glucuronides of arylamines such as 4-amino-
biphenyl or 2-naphthylamine are regarded (26) as
transport forms and proximate carcinogens which
release the ultimate carcinogen, the N-hydroxy
aglycone, upon mild acid (pH 5-6) conditions such as
exist in the urinary bladder of some species (25), or
upon hydrolysis with P-glucuronidase (19, 23). In five
separate determinations, we have found that the pH
of normal, 24 hr hamster urine to vary from pH 6.2
to 6.6. Under these conditions the N-glucuronides of
DMAB and N-hydroxy-DMAB may be extensively
hydrolyzed (Fig. 8). The absence of bladder tumors
in the rat in response to DMAB is likely due to the
preferential excretion of the N-hydroxy-N-glucuro-
nide in the bile rather than the urine in this species.
Extensive investigations (27, 28) into the relative
excretion of organic anions into the urine and bile of
rats have determined that a rather sharp molecular
weight threshold for biliary excretion in this species
exists; compounds below the molecular weight of
approximately 350 are excreted almost entirely in
the urine. Above 350 molecular weight the extent of
biliary excretion increases steeply as a function of
the molecular weight. Thus in the rat, the extents of
biliary excretion of the N-hydroxy-N-glucuronide of
DMAB (molecular weight 388) would be greater
than the corresponding metabolite of 3-methyl-4-
aminobiphenyl (molecular weight 374) which in turn
would be greater than that of N-hydroxy-N-
glucuronide of 4-aminobiphenyl (molecular weight
360). Interestingly, this correlates well with the
carcinogenicity of the parent amines for the colon
(Table 1). The excretion of the N-hydroxy-N-
glucuronide of DMAB in both hamster urine and
bile could be due to a higher molecular weight
threshold for biliary excretion in this species.
It is obvious that besides molecular weight other
factors, such as perhaps the degree ofN-hydroxyla-
ion and the reactivity of the ultimate carcinogen,
must also play a role in determining the organotrop-
ism and carcinogenicity of the 4-aminobiphenyl
derivatives, since the 2-methyl and the 3-methoxy
substituted compounds were observed to induce
tumors only in the liver and bladder of rats, respec-
tively (Table 1). Hecht et al. (15) have demonstrated
that DMAB is significantly more mutagenic in the
Ames assay than is 2'-methyl-4-aminobiphenyl and
that the same relationship holds for the correspond-
ingN-oxidized derivatives.
With respect to the carcinogenicity of DMAB to
the colon, bacterial enzymes may play a major role
in the further activation of the N-hydroxy-N-glucu-
ronide. Analogous metabolites of 2-naphthylamine
and AB have been found to be easily hydrolyzed to
the aglycones by E. coli p-glucuronidase (19); more-
over Reddy and Watanabe (8) have demonstrated
that germ-free status significantly reduces the inci-
dence of DMAB induced intestinal tumors in F344
rats.
Up to now relatively little information has been
available as to the metabolism of DMAB (5, 29).
However, Gorrod (30), in unpublished work, has de-
tected the N-glucuronide of DMAB in rat bile and
has obtained evidence for the oxidation of both the
3 and 2' methyl groups as well as for hydroxylation
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at the 4' position. Work on the more exact function
ofthe N-hydroxy-N-glucuronide in intestinal and uri-
nary bladder cancer as well as on the complete char-
acterization of the biliary and urinary DMAB me-
tabolites resolved by our Sephadex LH-20 method
is currently in progress in this laboratory.
This study was supported in part by NIOSH Grant OH-
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Joseph Camanzo and Ruth Young for the mass spectral
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